Résultats de la recherche - Longjiang She
- Résultat(s) 1 - 1 résultats de 1
-
1
Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma par Longjiang She, Longjiang She, Siqi Tang, Siqi Tang, Jiaqi Han, Jiaqi Han, Guichao Liu, Guichao Liu, Lusi Chen, Lusi Chen, Yang Zhang, Yang Zhang, Weijun Luo, Weijun Luo, Weihan Zuo, Weihan Zuo, Feng Ma, Feng Ma, Yan Xiong, Yan Xiong, Ning Zhang, Ning Zhang
Publié 2025-07-01ObjectivesThe recently released CONTINUUM trial was the first phase 3 randomized study to demonstrate the efficacy and safety of immunotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma (NPC), showing that sintilimab can bring clinical benefits to these populations.Materials and M...
Accéder au texte intégral
Article